Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Input metadata referenced "Encompass Health," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Quarterly Report).
Reporting Period: Three and six months ended June 30, 2001.
Business Overview: HealthSouth provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of June 30, 2001, the company operated approximately 1,913 locations across 50 states and several international jurisdictions.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2001 |
Three Months Ended June 30, 2000 |
Six Months Ended June 30, 2001 |
Six Months Ended June 30, 2000 |
|---|---|---|---|---|
| Revenues | $1,098,989 | $1,036,322 | $2,189,451 | $2,057,658 |
| Net (Loss) Income | $(19,947) | $65,213 | $55,364 | $130,539 |
| Net Income Per Share (Diluted) | $(0.05) | $0.17 | $0.14 | $0.33 |
| Operating Cash Flow (6mo) | $238,737 | $287,551 | ||
| Free Cash Flow (Approx. 6mo) | ||||
| Total Debt (Long-term + Current) | $3,101,239 | |||
| Cash and Cash Equivalents | $190,312 | |||
| Working Capital | $1,234,761 |
Note: Free Cash Flow is estimated as Operating Cash Flow less Capital Expenditures ($172,462) and Acquisitions ($5,031) for the six-month period.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 6.0% ($62.7M) for the quarter and 6.4% ($131.8M) for the six months compared to the prior year periods, driven primarily by increased patient volume.
- Profitability Decline: The company reported a net loss of $19.9M for the quarter ended June 30, 2001, compared to net income of $65.2M in the same period in 2000. This was primarily due to significant non-recurring charges.
- Unusual Charges: Total unusual and non-recurring charges for the quarter were approximately $164.9M, including:
- A $139.9M loss on the sale of substantially all occupational medicine operations and the Richmond, Virginia medical center.
- An $8.2M settlement with the U.S. Department of Justice.
- A $6.5M impairment charge related to the termination of a credit agreement.
- Expense Ratios: Operating expenses as a percentage of revenue improved to 65.8% for the quarter (down from 67.6% in 2000), despite the increase in corporate general and administrative expenses.
Guidance, Outlook, and Risks
- Capital Expenditure Outlook: Management anticipates spending approximately $100M to $150M on maintenance and expansion of existing facilities and $200M to $250M on development activities and the Integrated Service Model over the next twelve months.
- Liquidity: The company maintains a $1.75B revolving credit facility with $1.205B drawn as of June 30, 2001. Management believes existing cash, operating cash flow, and credit facilities are sufficient for the next twelve months.
- Legal Proceedings:
- DOJ Settlement: Settled a lawsuit regarding Medicare cost reports for $8.2M without admitting liability.
- Securities Litigation: Facing consolidated class-action lawsuits alleging misrepresentation of financial condition. The company denied the motion to dismiss the complaint and intends to vigorously defend the claims, though the outcome remains unpredictable.
- Reimbursement Risks: Significant revenue reliance on Medicare (35.2% of Q2 revenue) and Medicaid exposes the company to regulatory changes and reimbursement rate adjustments.
Investor Verification Checklist
- Asset Sale Proceeds: Verify the utilization of the $97.8M cash proceeds from the sale of occupational medicine operations and the Richmond medical center, specifically regarding debt paydown.
- Legal Exposure: Monitor the status of the consolidated securities litigation (In re HealthSouth Corporation Securities Litigation) and potential future liabilities.
- Reimbursement Rates: Assess the impact of potential changes in Medicare and Medicaid reimbursement policies on future margins, given the high concentration of government payors.
- Debt Structure: Review the terms of the $1.75B revolving credit facility and the recent issuance of $375M in 8.5% Senior Notes due 2008 to understand interest rate exposure and maturity profiles.
- Same-Store Performance: Analyze the 9.2% increase in same-store revenues to determine if organic growth trends are sustainable independent of acquisitions.